| |
Total (n = 40)
|
Non-mortality (n = 25)
|
Mortality (n = 15)
|
P-value
|
Non-recurrence
|
Recurrence
|
P-value
|
|---|
|
LC3 in tumors
|
|
Low
|
7 (17.5)
|
1 (4.0)
|
6 (40.0)
|
0.004
|
2 (6.7)
|
5 (50.0)
|
0.002
|
|
High
|
33 (82.5)
|
24 (96.0)
|
9 (60.0)
| |
28 (93.3)
|
5 (50.0)
| |
|
Beclin-1 in tumors
|
|
Low
|
15 (37.5)
|
7 (28.0)
|
8 (53.3)
|
0.109
|
9 (30.0)
|
6 (60.0)
|
0.09
|
|
High
|
25 (62.5)
|
18 (72.0)
|
7 (46.7)
| |
21 (70.0)
|
4 (40.0)
| |
|
p62 in tumors
|
|
Low
|
13 (32.5)
|
10 (40.0)
|
3 (20.0)
|
0.191
|
21 (70.0)
|
8 (80.0)
|
0.54
|
|
High
|
27 (76.5)
|
15 (60.0)
|
12 (80.0)
| |
9 (30.0)
|
2 (20.0)
| |
|
LC3 in ANT
|
|
Low
|
15 (37.5)
|
9 (36.0)
|
6 (40.0)
|
0.8
|
10 (33.3)
|
5 (50.0)
|
0.346
|
|
High
|
25 (62.5)
|
16 (64.0)
|
9 (60.0)
| |
20 (66.7)
|
5 (50.0)
| |
|
Beclin-1 in ANT
|
|
Low
|
17 (42.5)
|
10 (40.0)
|
7 (46.7)
|
0.68
|
11 (36.7)
|
6 (60.0)
|
0.196
|
|
High
|
23 (57.5)
|
15 (60.0)
|
8 (53.3)
| |
19 (63.3)
|
4 (40.0)
| |
|
p62 in ANT
|
|
Low
|
24 (60.0)
|
15 (60.0)
|
9 (60.0)
|
0.99
|
20 (66.7)
|
4 (40.0)
|
0.136
|
|
High
|
16 (40.0)
|
10 (40.0)
|
6 (40.0)
| |
10 (33.3)
|
6 (60.0)
| |
- ANT: Adjacent non-tumor tissues
